港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

670.135

+9.6471.46%

漲家數：17

跌家數：13

平家數：4

市盈率：- -

高：678.126

開：660.587

低：657.123

收：660.489

成交量：1.54億

成交額：46.33億

市值：4,299.47億

流通市值：3,802.52億

資料載入中...

總覽新聞資訊

康寧傑瑞製藥-B(09966)：KN026新輔助治療HER2陽性乳腺癌III期臨床研究達到主要終點

美股製藥公司Centessa Pharmaceuticals盤前拉升46%

每日经济新闻

禮來將以每股38美元外加或有價值權（CVR）的價格收購製藥公司Centessa Pharmaceuticals。

中國抗體-B(03681)：陳海剛辭任非執行董事

中國創新藥企在肺癌臨床研究中取得重大進展

新华社客户端

長江生命科技(00775)附屬順譜醫藥科技將在AACR 2026年會上展示治療性癌症疫苗研發系列的研究數據

33倍淨利增長，和鉑醫藥如何將BD變成常態化「印鈔機」？

21世纪经济报道

達安基因(002030.SZ)子公司取得一項醫療器械註冊證

恒瑞醫藥：創新藥收入突破163億，對外許可常態化打開增長新空間

证券市场周刊

九強生物(300406.SZ)子公司取得多項醫療器械註冊證

智通财经网

新華醫療(600587.SH)子公司產品獲得二類醫療器械註冊證

AI製藥商業化還不成熟？晶泰控股首次年度盈利，英硅智能依然虧損

4月份，這些新規將影響你我生活

上市後首份年報出爐，英硅智能如何以BD走穩商業化？

21世纪经济报道

醫保監管新規細化違法行為認定，重點打擊倒賣迴流藥、誘導住院

東曜藥業－Ｂ(01875)股價下跌8.127%，現價港幣$5.2

阿斯达克财经

港股微創心通-B午後一度跌近17%

每日经济新闻

創新藥概念午後再度活躍海創藥業升逾11%

每日经济新闻

2026年一季度創新藥BD交易突破600億美元！恒生創新藥ETF華泰柏瑞（520500）成交額顯著放量

加科思－Ｂ(01167)股價下跌5.125%，現價港幣$6.85

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":670.1354,"timestamp":1775117299351,"preClose":660.4887,"halted":0,"volume":153717417,"delay":0,"changeRate":0.014605,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":9.646667,"latestTime":"04-02 16:00:00","open":660.58655,"high":678.1257,"low":657.12256,"amount":4633342498,"amplitude":0.031799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"pbRate":5.274197,"peRate":-86.845688,"turnoverRate":0.005552,"increases":17,"decrements":14,"flats":2,"marketCap":429946652416,"floatMarketCap":380251567184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":678.1257,"amplitude":0.031799,"preClose":660.4887,"low":657.12256,"pbRate":"5.274197","latestPrice":670.1354,"volume":153717417,"delay":0,"open":660.58655,"prevYearClose":556.26263,"prevWeekClose":606.745,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":579.36,"twentyDayClose":522.155,"sixtyDayClose":580.971,"secType":"PLATE","market":"HK","turnoverRate":0.005552,"peRate":-86.845688,"marketCap":429946652416,"floatMarketCap":380251567184,"timestamp":1775117299351,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":17,"down":13,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623583940","title":"康寧傑瑞製藥-B(09966)：KN026新輔助治療HER2陽性乳腺癌III期臨床研究達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583940","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623583940?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 19:03","pubTimestamp":1774955020,"startTime":"0","endTime":"0","summary":"BC是中国女性发病率最高的恶性肿瘤，其中HER2阳性亚型约占20%至30%。该研究旨在比较KN026联合HB1801±卡铂对比曲妥珠单抗联合帕妥珠单抗和多西他赛±卡铂新辅助治疗早期和局部晚期HER2阳性BC的有效性及安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4134","09966","BK1161","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623644585","title":"美股製藥公司Centessa Pharmaceuticals盤前拉升46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623644585","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623644585?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 19:01","pubTimestamp":1774954897,"startTime":"0","endTime":"0","summary":"美股制药公司Centessa Pharmaceuticals盘前拉升46%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690598742.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690598742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623588240","title":"禮來將以每股38美元外加或有價值權（CVR）的價格收購製藥公司Centessa Pharmaceuticals。","url":"https://stock-news.laohu8.com/highlight/detail?id=2623588240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623588240?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 18:49","pubTimestamp":1774954168,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"044b49fac9463464d2e44ed274e1a9ed","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0672654240.SGD","LU2237443465.HKD","IE00BK4W5M84.HKD","IE00BWXC8680.SGD","IE00B2B36J28.USD","LU2168564149.EUR","LU2028103732.USD","LU0820561818.USD","LU2168564495.EUR","LU1548497426.USD","IE00BFSS8Q28.SGD","BK4161","LU1064131342.USD","LU2168564065.EUR","LU2271345857.HKD","LU0316494557.USD","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU2462157665.USD","LU2471134523.USD","LU2237443622.USD","LU2491049909.HKD","BK4588","LU1366192091.USD","LU2237443382.USD","BK4516","LU0106261372.USD","LU1232071149.USD","LU1988902786.USD","IE00BJT1NW94.SGD","LU2265009873.SGD","LU0432979614.USD","LU0225283273.USD","IE00BFSS7M15.SGD","LU1127390331.HKD","LU0061475181.USD","LU2361045086.USD","SG9999014898.SGD","CNTA","IE00BN29S564.USD","LU0203202063.USD","LU1061106388.HKD","IE0004445015.USD","LU0471298694.HKD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","IE00BKPKM429.USD","LU0354030511.USD","LU0079474960.USD","SG9999001176.SGD","LU2112291526.USD","LU2089283258.USD","LU0820561909.HKD","LU1720051108.HKD","LLII","LU2264538146.SGD","LU1720051017.SGD","LU0823434740.USD","LU2417539215.USD","LU0096364046.USD","LU1804176565.USD","LU2106854487.HKD","LU0158827948.USD","LU1291159041.SGD","LU2471134879.HKD","IE00B4R5TH58.HKD","LU0238689110.USD","BK1574","LU1629891620.HKD","IE00BJJMRY28.SGD","LU0882574055.USD","LU2552382215.SGD","IE00B7KXQ091.USD","BK4585","IE00BKDWB100.SGD","LU2756315318.SGD","IE0005OL40V9.USD","ELIS","LU2023250504.SGD","LU2211815571.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","SG9999018857.SGD","SGXZ31699556.SGD","LU1814569148.SGD","LU1868836914.USD","LU0058720904.USD","LU0289739699.SGD","BK4534","LU1093756168.USD","IE00B4JS1V06.HKD","LU0456855351.SGD","LU2360106947.USD","LLYX","LU1868837300.USD","LU1623119135.USD","LU2468319806.SGD","LU1057294990.SGD","LLYZ","LU0097036916.USD","LU0889565916.HKD","SG9999015986.USD","LU0466842654.USD","LU0640476718.USD","LU0964807845.USD","LU2756315664.SGD","SG9999018865.SGD","LU2491050154.USD","LU0210536198.USD","BK4599","LU2237443549.SGD","LU2237443895.HKD","SG9999014906.USD","LU2361044949.HKD","BK4581","BK4533","LU0353189680.USD","LU2168563687.JPY","LU0353189763.USD","LU0006306889.USD","LU0354030438.USD","LU0109391861.USD","LU1145028129.USD","LU2237443978.SGD","LU2461242641.AUD","LU0320765992.SGD","LU2237438978.USD","LU1917777945.USD","GB00BDT5M118.USD","LU0323591593.USD","LU2552382058.USD","LU2750360997.AUD","SG9999001176.USD","LU0820562030.AUD","IE00B1XK9C88.USD","LU1323610961.USD","IE0009355771.USD","LU2456880835.USD","SGXZ99366536.SGD","LU2089284900.SGD","LU0109394709.USD","LU1267930730.SGD","LU0094547139.USD","LU2089984988.USD","LU2471134952.CNY","SG9999014880.SGD","LU1069344957.HKD","SG9999015978.USD","LU1712237335.SGD","LU2023251221.USD","LU2087625088.SGD","LU0114720955.EUR","IE00B775H168.HKD","ELIL","BK4007","LU0882574139.USD","SG9999014914.USD","SG9999015952.SGD","LU2023250330.USD","IE0001KFT4U8.USD","SG9999013999.USD","LU1035775433.USD","LU0198837287.USD","LU1093756325.SGD","LU2236285917.USD","LU0471298777.SGD","LU2491050071.SGD","LU1280957306.USD","LU2602419157.SGD","LU0823416689.USD","LU0256863902.USD","LU2552382132.HKD","LU0122379950.USD","LU0787776722.HKD","BK1191","IE00BJJMRX11.SGD","LU1868836757.USD","IE0002141913.USD","LU0234572021.USD","LU0689472784.USD","LU0943347566.SGD","LU1868836591.USD","LU1974910355.USD","SGXZ81514606.USD","SGXZ51526630.SGD","LLY","LU0823434583.USD","LU1551013425.SGD","LU0256863811.USD","LU1868837136.USD","LU2746668974.SGD","SG9999017495.SGD","IE0004445239.USD","LU0708995401.HKD","SG9999015945.SGD","LU1983299246.USD","LU0158827781.USD","LU2063271972.USD","LU0786609619.USD","LU0203201768.USD","LU0320765059.SGD","LU2324357040.USD","LU2361044865.SGD","LU2746668461.USD","IE00BK4W5L77.USD","LU2213496289.HKD","LU0266013472.USD","LU2896262040.SGD","IE00BJLML261.HKD","LU0683600562.USD","LU0385154629.USD","LU2108987350.USD","LU2168564222.USD","LU1023059063.AUD","LU2471134796.USD","LU1989771016.USD","LU2357305700.SGD","LU1551013342.USD","LU2111349929.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623003403","title":"中國抗體-B(03681)：陳海剛辭任非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2623003403","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623003403?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 18:03","pubTimestamp":1774951429,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国抗体-B(03681)发布公告，陈海刚博士(陈博士)已提呈辞任非执行董事，自2026年3月31日起生效，以便投放更多时间于个人事务;及董汛先生(董先生)已提呈辞任非执行董事，自2026年4月1日起生效，乃由于其其他个人工作及业务承担。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623307027","title":"中國創新藥企在肺癌臨床研究中取得重大進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2623307027","media":"新华社客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623307027?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 17:54","pubTimestamp":1774950840,"startTime":"0","endTime":"0","summary":"新华社北京3月31日电近日，在丹麦哥本哈根举办的欧洲肺癌大会 上，四川药企百利天恒刷新“里程碑”：ADC联合免疫抑制剂一线治疗广泛期小细胞肺癌的II期研究结果正式公布。该项研究由同济大学附属东方医院周彩存教授牵头开展，周斐教授代表团队进行现场汇报。国家药监局相关负责人3月27日公开表示，截至目前，中国创新药已取得历史性突破，并且有望在“十五五”期间继续保持良好的发展势头。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-31/doc-inhswpmw5737804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623302237","title":"長江生命科技(00775)附屬順譜醫藥科技將在AACR 2026年會上展示治療性癌症疫苗研發系列的研究數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2623302237","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623302237?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 17:17","pubTimestamp":1774948639,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 发布公告，公司附属公司顺谱医药科技有限公司将在美国圣地牙哥举行的美国癌症研究协会2026 年度年会上，展示治疗性癌症疫苗研发系列的研究数据。此乃顺谱医药科技自成立以来发表的首个重要科研成果，展示以专有 TrueHLA Epitope-to-Efficacy转化设计框架，研究新一代癌症疫苗技术取得的重大进展。在发表中展示的该等数据充分印证顺谱医药科技从抗原筛选转化至功能性免疫反应及肿瘤控制上的优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00775","159646","159938","09939","BK1569","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304962","title":"33倍淨利增長，和鉑醫藥如何將BD變成常態化「印鈔機」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304962","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623304962?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 16:28","pubTimestamp":1774945680,"startTime":"0","endTime":"0","summary":"3月30日，和铂医药（02142.HK）公布了2025年度业绩。财报显示，公司全年总收入约11.1亿元人民币，同比增长314.6%；全年净利润约6.48亿元，同比增长33倍；经调整净利润约7.09亿元，同比增长11倍。截至2025年底，现金及现金等价物增至28.33亿元，较上年末增长141.6%。从账面数据看，这是一份颇为亮眼的成绩单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690416970.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690416970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","02142","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623301480","title":"達安基因(002030.SZ)子公司取得一項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2623301480","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623301480?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 16:17","pubTimestamp":1774945047,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因(002030.SZ)公告，公司下属控股子公司广州市达瑞生物技术股份有限公司取得国家药品监督管理局颁发的医疗器械注册证一个，相关医疗器械名称为：人类免疫缺陷病毒抗原抗体检测试剂盒(化学发光免疫分析法)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK1583","BK0168","BK0188","09996","BK1100","BK1222","09997","BK0159","BK1574","BK0046","BK0239","159883","BK0028","BK0122","002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623330120","title":"恒瑞醫藥：創新藥收入突破163億，對外許可常態化打開增長新空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2623330120","media":"证券市场周刊","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623330120?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 16:15","pubTimestamp":1774944914,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药（600276.SH）发布2025年年度报告。报告显示，公司全年实现营业收入316.29亿元，同比增长13.02%；实现归母净利润77.11亿元，同比增长21.69%；现金流达112.35亿元，同比增长51.36%。报告期间在创新药成果加速转化与对外许可收入常态化入账的双重驱动下，公司业绩实现稳健增长，经营质量持续优化，展现出从研发投入到商业变现的良性循环能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690397891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997244956.HKD","LU1997245094.SGD","LU2097828474.EUR","LU2543165471.USD","LU0359201885.HKD","LU1146622755.USD","BK1191","BK0196","LU1820825898.SGD","LU2289578879.USD","LU0359202008.SGD","LU1023057109.AUD","LU2148510915.USD","LU2097828805.USD","LU2328871848.SGD","BK0012","LU2097828714.EUR","LU1580142542.USD","06978","LU2495084118.USD","LU1064130708.USD","LU1655091616.SGD","LU1969619763.USD","LU2580892789.USD","01276","159992","LU1255011170.USD","LU2580892862.HKD","BK1161","LU1997245177.USD","BK0028","LU1328615791.USD","LU0359201612.USD","600276","BK0060","LU2097828557.USD","BK0239","BK0183","LU0405327148.USD","BK0188","LU0405327494.USD","LU2097828631.EUR","LU1781817850.SGD","LU2488822045.USD","LU1064131003.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623719309","title":"九強生物(300406.SZ)子公司取得多項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2623719309","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623719309?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 15:57","pubTimestamp":1774943861,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司全资子公司福州迈新生物技术开发有限公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》，产品名称为：HER2抗体试剂(免疫组织化学法)、孕激素受体抗体试剂(免疫组织化学法)、CD20抗体试剂(免疫组织化学法)。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","159883","BK0239","BK1222","BK1583","BK1100","BK0012","BK0077","09997","BK0046","09996","BK0028","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623330941","title":"新華醫療(600587.SH)子公司產品獲得二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2623330941","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623330941?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 15:49","pubTimestamp":1774943358,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗(600587.SH)发布公告，公司子公司山东新华医用环保设备有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，产品名称：医用中心吸引系统，适用范围：用于医院向手术室、抢救室、治疗室和病房终端提供负压，产生吸力。医用中心吸引系统注册证的取得使公司在医用气体工程领域升级为“核心设备+工程安装+售后服务”的一体化解决方案提供商，可与现有产品线形成协同，有效提升公司在医疗气体领域的综合竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1574","BK0028","159883","BK0251","BK1222","BK1583","BK1100","600587","09996","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623309692","title":"AI製藥商業化還不成熟？晶泰控股首次年度盈利，英硅智能依然虧損","url":"https://stock-news.laohu8.com/highlight/detail?id=2623309692","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623309692?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 15:29","pubTimestamp":1774942185,"startTime":"0","endTime":"0","summary":"作者：林昀肖被称为国内“AI制药双雄”的晶泰控股（02228.HK）和英硅智能（03696.HK），相继发布2025年年报。在发布年报同一日，英硅智能也公布一项与礼来（LLY）的合作，礼来获得由英硅智能的AI技术开发的一款GLP-1药物的独家销售权，首付款为1.15亿美元，交易总价最高可达27.5亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690352613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02228","01477","BK1191","BK1574","AIPO","BK1617","BK1141","CHAT","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623301354","title":"4月份，這些新規將影響你我生活","url":"https://stock-news.laohu8.com/highlight/detail?id=2623301354","media":"中安在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623301354?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 15:23","pubTimestamp":1774941780,"startTime":"0","endTime":"0","summary":"转自：央视新闻　　2026年4月起，一批新规正式施行，将解决信用修复、未成年人保护、医疗管理、消费维权 等多领域热点问题，直接影响我们的生活，一文了解。　　射频美容仪产品“持证上岗”　　国家药监局规定，今年4月1日起，射频治疗仪、射频皮肤治疗仪类产品，未依法取得医疗器械注册证的，不得生产、进口和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-31/doc-inhswicu3373113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1515","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930549","title":"上市後首份年報出爐，英硅智能如何以BD走穩商業化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930549","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623930549?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:49","pubTimestamp":1774939740,"startTime":"0","endTime":"0","summary":"3月29日，英硅智能公布了港股上市后的首份年报。紧随其后，英硅智能宣布与礼来达成27.5亿美元合作。根据协议，礼来将获得一项全球独家许可，用于开发、生产和商业化针对特定适应症、目前处于临床前开发阶段的、具有潜在“同类最佳”水平的新型口服治疗药物。此外，英硅智能与礼来还将围绕礼来选定的靶点开展多项研发项目合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690313762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690313762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1574","AIYY","BK4587","BK4551","AGIX","BK4135","BK4588","01477","BK4023","BK4543","CHAT","CNS","VGT","BK4585","BK4528","AIPO","AI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930562","title":"醫保監管新規細化違法行為認定，重點打擊倒賣迴流藥、誘導住院","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930562","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623930562?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:45","pubTimestamp":1774939500,"startTime":"0","endTime":"0","summary":"中国医保基金监管工作将迎来操作性更强的法律制度依据。　　4月1日起，《医疗保障基金使用监督管理条例实施细则》将正式施行。作为2021年发布的《医疗保障基金使用监督管理条例》的一部配套规章，《实施细则》对基金使用、监督检查、违法认定、法律责任等内容进行了系统细化。　　“比如违法行为的认定，仍需要进一步细化。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/insurance/bxyy/2026-03-31/doc-inhswicu3316117.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxyy/2026-03-31/doc-inhswicu3316117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","09939","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623305914","title":"東曜藥業－Ｂ(01875)股價下跌8.127%，現價港幣$5.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2623305914","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623305914?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:35","pubTimestamp":1774938900,"startTime":"0","endTime":"0","summary":"[下跌股]东曜药业－Ｂ(01875) 股价在下午02:35比前收市价下跌8.127%，现股价为港币$5.2。至目前为止，今日最高价为$5.7，而最低价为$5.2。总成交量为280.28万股，总成交金额为港币$1.519千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312621/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312621/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01875","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623038483","title":"港股微創心通-B午後一度跌近17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623038483","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623038483?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 14:11","pubTimestamp":1774937489,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月31日，微创心通-B(02160.HK)午后一度跌近17%，截至发稿跌14.38%，报2.62港元，成交额1386.11万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690267428.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690267428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02160","BK1583","BK4585","BK4588","VXUS","BK1100","BK1239","BK1574","BK1225","02918"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623308309","title":"創新藥概念午後再度活躍 海創藥業升逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623308309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623308309?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:50","pubTimestamp":1774936200,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月31日，创新药概念午后再度活跃，海创药业涨超11%，此前津药药业、凯莱英涨停，双鹭药业、首药控股、亚太药业、威尔药业、万邦德、诚达药业跟涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690242481.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690242481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","688302","06978","BK0239","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623701133","title":"2026年一季度創新藥BD交易突破600億美元！恒生創新藥ETF華泰柏瑞（520500）成交額顯著放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2623701133","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623701133?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:36","pubTimestamp":1774935360,"startTime":"0","endTime":"0","summary":"今日早盘，创新药板块延续回暖态势，相关ETF交投火热。　　Wind数据显示，当前全市场仅有的跟踪恒生创新药指数的ETF产品——恒生创新药ETF华泰柏瑞成交额近期显著放量。2026年3月28日，据国家药监局发布信息显示，2026年一季度我国创新药BD交易总额已突破600亿美元，接近2025年全年总额的一半；交易数量达53件，首付款超33亿美元，规模与增速均创历史同期新高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-03-31/doc-inhswawe2210437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","520500","BK1161","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623370988","title":"加科思－Ｂ(01167)股價下跌5.125%，現價港幣$6.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2623370988","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623370988?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 13:15","pubTimestamp":1774934100,"startTime":"0","endTime":"0","summary":"[下跌股]加科思－Ｂ(01167) 股价在下午01:15比前收市价下跌5.125%，现股价为港币$6.85。至目前为止，今日最高价为$7.34，而最低价为$6.85。总成交量为127.23万股，总成交金额为港币$909.862万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312197/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603312197/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":7,"totalSize":383,"code":"91000000","status":"200"}]}}